How many insider trades does FilingIQ track for ANVS?

FilingIQ tracks 83 Form 4 insider transactions for ANVS (Annovis Bio, Inc.), covering filings from Jan 31, 2020 onwards. 1 of those were filed in the last 90 days.

Are ANVS insiders net buyers or net sellers?

Across the full Form 4 history for ANVS, 28 transactions (34%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ANVS insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ANVS in?

Annovis Bio, Inc. (ANVS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $64.65M.

ANVS insider trading

NYSE Healthcare

Annovis Bio, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

34% / 0%

Market cap

$64.65M

About Annovis Bio, Inc.

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 2/3 to treat alzheimer's disease, as well as in phase 3 to treat parkinson's disease; and is in phase 2 clinical trial to treat lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia. Annovis Bio, Inc. was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.

Company website: www.annovisbio.com

ANVS insider activity at a glance

FilingIQ has scored 83 insider transactions for ANVS since Jan 31, 2020. The most recent filing in our index is dated Apr 2, 2026.

Across the full history, 28 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ANVS insider trades is 51.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ANVS trades on FilingIQ Raw filings on SEC EDGAR

Latest ANVS Form 4 filings

Maccecchini Maria-Luisa President & CEO

P Oct 28, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading ANVS

Maccecchini Maria-Luisa

3 trades · score 71.0

Frequently asked

How many insider trades does FilingIQ track for ANVS?: FilingIQ tracks 83 Form 4 insider transactions for ANVS (Annovis Bio, Inc.), covering filings from Jan 31, 2020 onwards. 1 of those were filed in the last 90 days.
Are ANVS insiders net buyers or net sellers?: Across the full Form 4 history for ANVS, 28 transactions (34%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ANVS insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ANVS in?: Annovis Bio, Inc. (ANVS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $64.65M.

Methodology & sources

Every ANVS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.